Recent news on Pioglitazone Hcl

Application for an Additional Indication of Combination Therapy of ...  -  Apr 23, 2007
PipelineReview.com (press release),Insulin-resistance is a condition where the body does not effectively use the insulin it produces, and pioglitazone HCl, which is insulin sensitizer

Pioglitazone Linked to Fracture Risk in Women  -  Mar 9, 2007
Medscape (subscription)Pioglitazone HCl is currently marketed as a single drug (Actos) and in combination with metformin HCl (Actoplus met) or glimepiride (duetact,

Takeda Announces Submission Of Application For Additional ...  -  Jan 28, 2007
Medical News Today (press release),Takeda Pharmaceutical Company Limited announced that today it submitted an application for an additional indication of ACTOS(R) (pioglitazone HCl) with

Marketing Authorisation Granted for Tandemact (TM) (pioglitazone ...  -  18 Jan 2007
PipelineReview.com (press release),The two approved strengths for Tandemact™ are pioglitazone HCl/glimepiride 30mg/4mg and 45mg/4mg. "We are very pleased with this approval of Tandemact™,

Takeda Announces Positive Opinion From European Regulatory ...  -  Jan 4, 2007
Medical News Today (press release),Products for Human Use ("CHMP") of the European Medicines Agency ("EMEA"), recommending to grant the new indication for ACTOS(R) (pioglitazone HCl).

Positive Opinion From European Regulatory Authorities for ...  -  Dec 21, 2006
PipelineReview.com (press release),Committee for Medicinal Products for Human Use of the European Medicines Agency, recommending to grant the new indication for ACTOS® (pioglitazone HCl).

Takeda Announces Positive Opinion from European Regulatory ...  -  Dec 20, 2006
PharmaLive.com (press release),Products for Human Use ("CHMP") of the European Medicines Agency ("EMEA"), recommending to grant the new indication for ACTOS(R) (pioglitazone HCl).

duetact(TM) (pioglitazone HCl and glimepiride) Now Available in US ...  Nov 7, 2006
New product offers ACTOS(R) (pioglitazone HCl) and glimepiride, two commonly used diabetes medications, in a single tablet; giving physicians and patients ... -PR Newswire (press release), ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements ...  Sep 15, 2006
...presented today at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) indicated that ACTOS(R) (pioglitazone HCl), an oral ... -Medical News Today

New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of ...  Sep 3, 2006
3 /PRNewswire/ -- Results of new analyses found that ACTOS® (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent ... -Yahoo! News

New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk Of ...  Sep 4, 2006
Results of new analyses found that ACTOS(R) (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent stroke in high ... -Medical News Today

New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of ...  Sep 3, 2006
3, 2006--Results of new analyses(3) found that ACTOS(R) (pioglitazone HCl), an oral antidiabetic medication(4), significantly reduced the risk of recurrent ... -Business Wire

Pioglitazone HCl Demonstrates Significant Improvements in ...  Sep 14, 2006
...presented today at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) indicated that Actos® (pioglitazone HCl), an oral ... -DG News

Type 2 Diabetes: Treatment and Prevention  Sep 17, 2006
...failure. In a second study, German researchers tested the diabetes drug pioglitazone HCl (ACTOS) on patients with the disease. It's ... -Ivanhoe

(PRN) - Noble Financial Selects Mediasite to Webcast Investment ...  Sep 14, 2006
...(PRN) - ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients with Type 2 Diabetes ... [+. ... -Bolsamania.com

Takeda Says New Study Shows ACTOS Lowers Risk Of Secondary Stroke ...  Sep 3, 2006
...unit of Japan-based Takeda Pharmaceutical Company Limited (TKPHF.PK) said on Sunday that results of new analyses found that ACTOS or pioglitazone HCl, an oral ... -Trading Markets

Actos reduces stroke risk in diabetes  Sep 6, 2006
BARCELONA, Spain, Sept. 6 (UPI) -- Actos (pioglitazone HCl) reduces insulin resistance and also lowers the risk of a second stroke by half, US researchers say. ... -United Press International

New Data Show ACTOS (pioglitazone HCl) Halted Progression Of ...  -  Nov 18, 2006
Medical News Today (press release),On 13-Nov-2006 researchers presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid

New data show ACTOS(r) (pioglitazone HCl) halted progression of ...  -  Nov 13, 2006
EurekAlert (press release),Chicago, IL, November 13, 2006 -- Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as

New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of ...  -  Nov 13, 2006
Drug Newswire (press release),13 /PRNewswire/ -- Researchers today presented data showing that ACTOS(R) (pioglitazone HCl) halted the progression of atherosclerosis as measured by

New Data Show ACTOS® (pioglitazone HCl) Halted Progression  -  Nov 13, 2006
Newswise (press release)Newswise — Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid

New Data Show Actos (pioglitazone HCl) Halted Progression of ...  -  Nov 13, 2006
PharmaLive.com (press release),CHICAGO, November 13, 2006 /PRNewswire/ -- Researchers today presented data showing that ACTOS(R) (pioglitazone HCl) halted the progression of

Business Updates  -  Nov 13, 2006
The Daily Yomiuri,Duetact combines ACTOSR (pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet.

(PRN) - American Woodmark Corporation Announces Second Quarter ...  -  Nov 13, 2006
Bolsamania.com,...(PRN) - New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients with Type 2 Diabetes ... [+]

FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for ...  Jul 30, 2006
...(TPNA) announced that the US Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for duetact(TM) (pioglitazone HCl and glimepiride ... -Yahoo! News

International Approvals: Januvia, Competact, Gardasil  Aug 14, 2006
...phosphate for once-daily administration in the treatment of type 2 diabetes mellitus; the European Commission has approved pioglitazone HCl plus metformin HCl ... -Medscape (subscription)

Marketing Authorisation Granted for Competact (pioglitazone ...  Aug 3, 2006
...("TGRD Europe") was granted a marketing authorisation for Competact™, a fixed combination tablet of ACTOS® (pioglitazone HCl) 15mg and metformin HCl 850mg ... -PharmaLive.com

EC approves Takeda's antidiabetic Competact  Aug 8, 2006
Commission has approved Japanese drug giant Takeda's marketing authorization for Competact, its fixed-combination tablet of Actos (pioglitazone HCl) 15mg and ... -Therapeutics Daily (subscription)

(PRN) - Dresdner Factoring AG: Receivables Turnover Well Above ...  Jul 31, 2006
Ltd. in China ... [+. PRN) - FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes ... [+. ... -Bolsamania.com

(PRN) - Following Is a Test Release ... [+]  Jul 30, 2006
...(PRN) - FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes ... [+. PRN) - Shell Issues ... -Bolsamania.com

Diabetes Drug May Help Treat Alzheimer's  Jul 21, 2006
The drug, called pioglitazone HCl, was tested in a placebo-controlled trial involving 25 people with mild to moderate Alzheimer's. ... -Consumer Affairs

Start of Phase III Clinical Program in the USof Fixed Dose ...  Jul 21, 2006
Development Center, Inc., has started the phase 3 clinical program of fixed dose combination product of Actos(R) (generic name: pioglitazone HCl) and Takeda's ... -PharmaLive.com

New Treatments for Alzheimer's on the Horizon  Jul 19, 2006
The drug is called pioglitazone HCl. In a trial of 25 people with mild to moderate Alzheimer's, the drug appeared to slow the progression of the disease. ... -Ivanhoe

Diabetes Drug Shows Promise in Treating Alzheimer’s  Jul 17, 2006
The drug, called pioglitazone HCl, was tested in a placebo-controlled trial involving 25 people with mild to moderate Alzheimer’s. The study assessed the ... -SeniorJournal.com

Takeda's Investigational Compound TAK-491 For Treatment Of ...  Jul 17, 2006
...this important class of drugs, and is expected to support the expansion of the US diabetic franchise of Actos® (generic name; pioglitazone HCl) into Lifestyle ... -Medical News Today

Takeda's Investigational Compound TAK-491 for Treatment of ...  Jul 11, 2006
...pioglitazone HCl) into Lifestyle-related diseases, and to further enhance the presence in the European cardiovascular market established by Candesartan. -PipelineReview.com



Takeda Submits New Drug Application For Extended-release Type 2 ...  Apr 6, 2006
...has submitted a New Drug Application (NDA) for an extended-release version of the combination medication ACTOplus met TM (pioglitazone HCl and metformin HCl ... - Medical News Today

Andrx Announces Filing of NDA by Takeda for ACTOS and Extended ...  Apr 4, 2006
...filed a New Drug Application (NDA) for a combination product consisting of Takeda's ACTOS(R) (pioglitazone HCl) and Andrx's extended-release metformin to the ... - Genetic Engineering News

(PRN) - Ameristar Casinos Submits All-Cash Proposal to Acquire ...  Apr 3, 2006
...[+]. (PRN) - Takeda Submits New Drug Application for Extended-Release Type 2 Diabetes Medication, ACTOplus met(TM) (pioglitazone HCl and metformin HCl) ... [. ... - Bolsamania.com



Takeda wins patent infringement case  Feb 24, 2006
...property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl). ... - News-Medical.net,

(PRN) - Resistance to Change Affects eClinical Trials Technology ...  Feb 22, 2006
Crystallography ... [+. PRN) - Takeda Wins Patent Infringement Litigation Against ANDA Filers for Generic ACTOS(R) (pioglitazone HCl) ... [. ... - Bolsamania.com,

Rich Daly Joins TAP As Senior Marketing Executive  Feb 2, 2006
...member of the senior leadership team that built Takeda's commercial infrastructure and successfully launched the diabetes drug Actos(R) (pioglitazone HCl). ... - International News Service,

Rich Daly Joins TAP As Senior Marketing Executive  Feb 2, 2006
...member of the senior leadership team that built Takeda's commercial infrastructure and successfully launched the diabetes drug Actos(R) (pioglitazone HCl). ... - International News Service

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional